Results 201 to 210 of about 75,213 (253)

Leveraging extracellular vesicle biology for novel tests and therapeutics for kidney fibrosis

open access: yesClinical and Translational Medicine, Volume 16, Issue 4, April 2026.
Extracellular vesicles (EVs) are bilipid membrane‐encased nanoparticles that play critical roles as cell‐to‐cell messengers and waste management mechanisms. EVs cargos can be leveraged as biomarkers to develop minimally invasive tests for kidney fibrosis and guide personalised mechanism‐driven care.
Chin‐Ya Sophie Chiang   +3 more
wiley   +1 more source

Circulating Molecular Drivers of Bone Remodeling in Pancreatitis. [PDF]

open access: yesClin Transl Gastroenterol
Hill RL   +8 more
europepmc   +1 more source

ZFP36L1 promotes non‐small cell lung cancer progression under hypoxia by modulating CXCL9:SPP1 polarity: A single‐cell transcriptomic study

open access: yesClinical and Translational Medicine, Volume 16, Issue 4, April 2026.
1. Under hypoxia, downregulating the CXCL9:SPP1 ratio in macrophages promoted malignant progression of non‐small cell lung cancer (NSCLC). 2. Transcriptional factor ZFP36L1 modulated the CXCL9:SPP1 macrophage polarity. 3. ZFP36L1‐driven SPP1+ macrophages could accelerate NSCLC progression by binding to CD44 on the tumour cell surface.
Lijie Wang   +7 more
wiley   +1 more source

Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma

open access: yesClinical and Translational Medicine, Volume 16, Issue 4, April 2026.
Extracellular vesicles mediate melanoma progression by transferring biomolecules (proteins, nucleic acids) that reshape the tumour microenvironment, promote immune evasion and drive metastasis. They also serve as diagnostic biomarkers and engineered therapeutic carriers for targeted therapy.
Junshu Li   +3 more
wiley   +1 more source

Optimizing graphene-enhanced polycaprolactone scaffolds for bone tissue engineering. [PDF]

open access: yesJ Oral Biol Craniofac Res
Anitasari S   +6 more
europepmc   +1 more source

Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin

open access: yesClinical and Translational Medicine, Volume 16, Issue 4, April 2026.
• Circulating soluble CD163 is elevated in ischaemic cardiomyopathy and correlates with systolic dysfunction severity and ventricular dilation. • Macrophage CD163 protects against post‐infarction systolic dysfunction and left ventricular dilation in mice. • Loss of CD163 decreases macrophage osteopontin expression.
Jingyu Chen   +18 more
wiley   +1 more source

Osteogenic Differentiation Triggered by Intracellular Magnetoelectric Stimulation of Core-Shell Nanotransducers under Remotely Applied Magnetic Fields. [PDF]

open access: yesACS Nano
Mendes MC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy